SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 Phase III SWOG S1207 Trial: Evaluating Adjuvant ET +/- 1 Year of Everolimus in Patients With High-Risk HR+/HER2- BC
By
SABCS 2022 Conference Coverage
FEATURING
Mariana Chavez Mac Gregor
By
SABCS 2022 Conference Coverage
FEATURING
Mariana Chavez Mac Gregor
51 views
December 14, 2022
Login to view comments.
Click here to Login
Videos